We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Blood Stem Cell May Help Repair Bone

By Biotechdaily staff writers
Posted on 25 Aug 2004
A single type of primitive stem cell, transplanted from donor mice, gave rise to both blood-forming and bone-forming cells in recipient mice, suggesting that it may someday be the basis of new medical treatments to replace or repair bone lost to disease or injury.

Researchers used a technique called retroviral insertion site analysis to determine which type of bone marrow cell from mice could give rise to bone-producing cells when transplanted into recipient mice. More...
In this technique, researchers add a piece of DNA marked with a green fluorescent protein to bone marrow cells taken from donor mice. The added DNA inserts itself randomly into one of the chromosomes and is duplicated each time the cell replicates. The daughter cells of the originally marked cell were identified by locating the marker in the same site of the chromosome in each succeeding generation.

Using this technique, the researchers at St. Jude Children's Research Hospital (Memphis, TN, USA) followed the fates of the cells removed from donor mice and transplanted into recipient mice whose own marrow cells had been destroyed by radiation. The cells identified in this study seem to be better able to engraft in bone than other bone marrow cells called mesenchymal cells. However, the osteoblasts that arose from donor cells were detectable for only several months in recipient mice, as occurs in human bone marrow transplant patients.

This suggests that repair and regeneration during the first few months after transplantation is driven by the transplanted donor cells that engraft in bones of the recipient. However, long-term maintenance of bone strength may be primarily controlled by other cells already present in the recipient's bone. The results of the research were reported in the August 10, 2004, issue of the Proceedings of the [U.S.] National Academy of Sciences.

"Our findings in mice coupled with previous experience with bone marrow transplantation in humans suggest that we have identified primitive cells in mice that are responsible for bone repair and regeneration,” said senior author Edwin Horwitz, M.D., Ph.D., associate member of the department of hematology/oncology at St. Jude.




Related Links:
St. Jude Med. Ctr

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.